BEIJING, Feb. 17 (Xinhua) -- Shares already listed on China's science and technology innovation board by the end of 2019 rose 35.46 percent on average from January 1 to February 13 of this year, reported Xinhua Finance, a national financial information platform run by Xinhua News Agency.
The platform citing a report with www.simuwang.com, a one-stop wealth management services provider said that private equity firms had different prospects about the following trends of stocks on the board.
By February 13, a total of 82 firms had went public on Shanghai's new Nasdaq-style sci-tech innovation board. Among them,17 firms hailed increases of over 200 percent on the first trading day when their stocks got listed on the board and six even embraced more than 300 percent of rises on the first trading day.
Since July when the board was inaugurated, a round of steep rise occurred, followed by a round of deep retreatment afterwards. However, after November 2019, the board welcomed another round of strong rally together with sharp rises of many new stocks in the first trading day.
As for the future, analysts with Leadway Asset Management Co., Ltd. thought current upturn of shares on the board mainly benefited from China’s monetary policy environment. Given the unlocking of original issue stocks in the second half of this year, supply is likely to surge by then, said analysts, advising investors remain rational and do not pin hopes on excessive bull runs this year,
The research team of YZAMC expressed a more optimistic view, saying that investment opportunities of the sci-tech innovation board this year mainly exist in four sectors such as semiconductor manufacturing, software sector including cloud computing, the Internet of Things and artificial intelligence, online education sector and quality bio-pharmaceutical firms.
After the epidemic ends, public health policies and medical treatment habits of people in China are expected to change much, which may bring attentions and supports to the bio-pharmaceutical companies, according to the team.
Li Yuankai, vice president of the investment department of Shantou Huayan Investment Co., Ltd. was optimistic about the running of the sci-tech innovation board this year. As Li reckoned, the board may produce better investment opportunities for the main board in 2020 as its key driving force the science and technology-based growth potential of firms on the board did not change, not to mention multiple positive factors including inclusion of stocks listed on the board into the MSCI indexes. (Edited by Duan Jing, duanjing@xinhua.org)
A single purchase
